Altamira Therapeutics Ltd.: total_liabilities
| Value | {"unit": "CHF", "value": 840677, "concept": "us-gaap:Liabilities"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bc8babe0-ccd5-4ba6-9a81-e269259ada0b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-21-018959Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001601936/total-liabilities/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bc8babe0-ccd5-4ba6-9a81-e269259ada0b
History
- no predecessors — first report